Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-08-07

FDA Approved: SKYLA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for SKYLA (levonorgestrel) submitted by Bayer HealthCare Pharmaceuticals Inc. The approval updates SKYLA's labeling for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SKYLA (LEVONORGESTREL)

Snippet

SUPPL AP for SKYLA (LEVONORGESTREL)